BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 16874751)

  • 1. New developments of brain imaging for Parkinson's disease and related disorders.
    Piccini P; Brooks DJ
    Mov Disord; 2006 Dec; 21(12):2035-41. PubMed ID: 16874751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging approaches to Parkinson disease.
    Brooks DJ
    J Nucl Med; 2010 Apr; 51(4):596-609. PubMed ID: 20351351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features, diagnosis, and imaging of parkinsonian syndromes.
    Poewe W
    Curr Opin Neurol Neurosurg; 1993 Jun; 6(3):333-8. PubMed ID: 8507902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion tensor imaging in a rat model of Parkinson's disease after lesioning of the nigrostriatal tract.
    Van Camp N; Blockx I; Verhoye M; Casteels C; Coun F; Leemans A; Sijbers J; Baekelandt V; Van Laere K; Van der Linden A
    NMR Biomed; 2009 Aug; 22(7):697-706. PubMed ID: 19378292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.
    Rango M; Arighi A; Biondetti P; Barberis B; Bonifati C; Blandini F; Pacchetti C; Martignoni E; Bresolin N; Nappi G
    Funct Neurol; 2007; 22(2):75-9. PubMed ID: 17637209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Acute dopaminergic responsiveness test in diagnosis of Parkinson's disease and Parkinsonian disorders].
    Li W; Feng T; Wang YJ; Lin JX; Xu XT
    Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2347-9. PubMed ID: 19087697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological, genetic, pharmacological, kinesiological, nuclear medical (IBZM-SPECT), standard and functional MRI studies on Parkinson's disease and related disorders and economic evaluation of Parkinson's disease therapy--clinical projects in the BMFT-research program Munich: "Parkinson's disease and other basal ganglia disorders".
    Oertel WH; Trenkwalder C; Gasser T; Schwarz J; Bucher SF; Eichhorn T; Pogarell O; Künig G; Arnold G; Bandmann O
    J Neural Transm Suppl; 1995; 46():325-37. PubMed ID: 8821069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimaging of nonmotor features of Parkinson's disease.
    Deblieck C; Wu AD
    Rev Neurol Dis; 2008; 5(3):125-33. PubMed ID: 18838952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional imaging in Parkinson disease.
    Nandhagopal R; McKeown MJ; Stoessl AJ
    Neurology; 2008 Apr; 70(16 Pt 2):1478-88. PubMed ID: 18413571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional metabolic changes in parkinsonian patients with normal dopaminergic imaging.
    Eckert T; Feigin A; Lewis DE; Dhawan V; Frucht S; Eidelberg D
    Mov Disord; 2007 Jan; 22(2):167-73. PubMed ID: 17133454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging neurodegeneration in Parkinson's disease.
    Pavese N; Brooks DJ
    Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain magnetic resonance imaging (MRI) in parkinsonian disorders.
    Sitburana O; Ondo WG
    Parkinsonism Relat Disord; 2009 Mar; 15(3):165-74. PubMed ID: 19059803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of Parkinson's disease].
    Arias-Rodríguez M; Morís-De la Tassa G
    Rev Neurol; 2009 Jan; 48 Suppl 1():S21-5. PubMed ID: 19222011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging in Parkinson's disease: from pathology to diagnosis.
    Stoessl AJ
    Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S55-9. PubMed ID: 22166455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging of Parkinson's disease and atypical parkinsonism.
    Zgaljardic DJ; Feigin A
    Curr Neurol Neurosci Rep; 2004 Jul; 4(4):284-9. PubMed ID: 15217542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging of L-dopamine and dopamine agonist therapy - revisited.
    Fukuyama H
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S53-7. PubMed ID: 19131045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging in manganism.
    Kim Y
    Neurotoxicology; 2006 May; 27(3):369-72. PubMed ID: 16442160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic criteria and differential diagnosis of Parkinson disease].
    Takáts A
    Ideggyogy Sz; 2003 May; 56(5-6):144-54. PubMed ID: 12861955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroimaging: current role in detecting pre-motor Parkinson's disease.
    Godau J; Hussl A; Lolekha P; Stoessl AJ; Seppi K
    Mov Disord; 2012 Apr; 27(5):634-43. PubMed ID: 22508281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.